GWM
ARKG icon

Geneos Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Geneos Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$444K Sell
10,561
-1,961
-16% -$62.4K 0.01% 770
2026
Q1 		$331K Hold
12,522
– – 0.01% 808
2025
Q4 		$363K Sell
12,522
-1,402
-10% -$42.1K 0.01% 757
2025
Q3 		$387K Hold
13,924
– – 0.01% 724
2025
Q2 		$339K Buy
13,924
+3,224
+30% +$70.6K 0.01% 823
2025
Q1 		$222K Hold
10,700
– – 0.01% 869
2024
Q4 		$252K Hold
10,700
– – 0.01% 768
2024
Q3 		$274K Buy
10,700
+1,135
+12% +$28.9K 0.01% 689
2024
Q2 		$225K Sell
9,565
-146
-2% -$3.69K 0.01% 678
2024
Q1 		$279K Sell
9,711
-15
-0.2% -$451 0.01% 620
2023
Q4 		$319K Buy
9,726
+1,677
+21% +$45.6K 0.02% 565
2023
Q3 		$224K Hold
8,049
– – 0.01% 654
2023
Q2 		$274K Buy
8,049
+35
+0.4% +$1.1K 0.01% 604
2023
Q1 		$241K Buy
8,014
+1,394
+21% +$43.2K 0.01% 611
2022
Q4 		$187K Sell
6,620
-39,854
-86% -$1.26M 0.01% 639
2022
Q3 		$1.53M Sell
46,474
-366
-0.8% -$13.4K 0.11% 195
2022
Q2 		$1.53M Sell
46,840
-29
-0.1% -$1.01K 0.08% 240
2022
Q1 		$2.15M Buy
46,869
+10,212
+28% +$487K 0.09% 213
2021
Q4 		$2.24M Sell
36,657
-217
-0.6% -$15K 0.09% 239
2021
Q3 		$2.76M Buy
36,874
+2,648
+8% +$222K 0.11% 198
2021
Q2 		$3.15M Sell
34,226
-560
-2% -$47.6K 0.12% 183
2021
Q1 		$3.09M Sell
34,786
-433
-1% -$43K 0.09% 230
2020
Q4 		$2.98M Buy
35,219
+9,677
+38% +$771K 0.12% 185
2020
Q3 		$1.59M Buy
25,542
+10,550
+70% +$618K 0.08% 231
2020
Q2 		$757K Hold
14,992
– – 0.04% 327
2020
Q1 		$470K Buy
+14,992
New +$501K 0.03% 385

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Geneos Wealth Management's ARKG Position: Q2 2026 in Review

Geneos Wealth Management reduced its ARK Genomic Revolution ETF (ARKG) stake by 16% in Q2 2026, selling an estimated $62.4K and leaving 10,561 shares worth $444K. The position accounts for 0.01% of the portfolio, ranked #770.

Geneos Wealth Management first reported a position in ARKG in Q1 2020 and has held it in 26 quarters since. The position peaked at $3.15M in Q2 2021. 273 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Geneos Wealth Management held 10,561 shares of ARK Genomic Revolution ETF worth $444K as of Q2 2026.
  • Geneos Wealth Management sold 1,961 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $62.4K.
  • ARK Genomic Revolution ETF made up 0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #770 holding.
  • Geneos Wealth Management first reported a position in ARK Genomic Revolution ETF in Q1 2020 and has held it in 26 quarters since.
  • Geneos Wealth Management's ARK Genomic Revolution ETF position peaked at $3.15M in Q2 2021.
  • 273 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.